Prevalence and risk factors of pre-hypertension and high blood pressure among adolescents in Cameroonian schools.


Journal

Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554

Informations de publication

Date de publication:
09 2023
Historique:
revised: 19 07 2023
received: 05 05 2023
accepted: 01 08 2023
medline: 13 9 2023
pubmed: 10 8 2023
entrez: 10 8 2023
Statut: ppublish

Résumé

Blood pressure (BP) is the main driver of mortality with 12.8% of all deaths worldwide. Adolescents are not spared, precisely in Cameroon where they constitute more than half of its population. The objective of our work was to describe the prevalence and risk factors of pre-hypertension and high blood pressure (HBP) among adolescents in Cameroonian schools. Descriptive study over 5 months; from January to May 2019. The study population consisted of students from private and public schools in the city of Douala. Sociodemographic, anthropometric, and personal background data were collected. Physical activity (PA) was assessed using the short International Physical Activity Questionnaire (IPAQ). Multivariate logistic regression was used to determine factors associated with pre-hypertension and HBP. Differences were considered significant for p < .05. We recruited 771 students with an average age of 16 ± 1 years with female predominance (51.4%). The prevalences of pre-hypertension and HBP were 6.6% and 3%, respectively. Overweight/obesity (OR = 4.6; p < .0001), hyperglycemia [(OR = 4.06; p = .001)] physical inactivity (OR = 1.85; p = .019), and public institutions (OR = 1.87; p = .02) were associated with pre-hypertension. Similarly, overweight/obesity (OR = 2.99; p = .022), hyperglycemia (OR = 14.05; p < .0001), and physical inactivity (OR = 8.58; p < .0001) were correlated with HBP. Pre-hypertension and HBP are high in Cameroonian school adolescents and their risk factors are overweight/obesity, hyperglycemia, and physical inactivity.

Identifiants

pubmed: 37561361
doi: 10.1111/jch.14711
pmc: PMC10497023
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

845-852

Informations de copyright

© 2023 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.

Références

Vasc Health Risk Manag. 2007;3(1):139-49
pubmed: 17583184
Circulation. 2008 Jun 24;117(25):3171-80
pubmed: 18559702
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
pubmed: 15286277
Sci Rep. 2019 Jul 1;9(1):9493
pubmed: 31263167
Rev Mal Respir. 2009 Mar;26(3):291-7
pubmed: 19367203
J Clin Hypertens (Greenwich). 2023 Sep;25(9):845-852
pubmed: 37561361
Ital J Pediatr. 2013 Nov 02;39:70
pubmed: 24180427
J Sci Med Sport. 2011 Jul;14(4):317-24
pubmed: 21444243
Exerc Sport Sci Rev. 2012 Jan;40(1):13-21
pubmed: 21918458
J Pediatr. 1984 Jan;104(1):147-51
pubmed: 6690660
Med Trop (Mars). 2006 Jun;66(3):241-6
pubmed: 16924814
Int J Obes (Lond). 2014 Jul;38(7):959-65
pubmed: 24304596
PLoS One. 2019 Jan 10;14(1):e0210591
pubmed: 30629671
Int J Obes (Lond). 2008 Nov;32 Suppl 5:S42-8
pubmed: 19011653
Pan Afr Med J. 2018 Oct 25;31:145
pubmed: 31037205
J Clin Hypertens (Greenwich). 2005 Feb;7(2):102-9
pubmed: 15722655
Pediatrics. 2007 Feb;119(2):237-46
pubmed: 17272612
Lancet. 2021 Sep 11;398(10304):957-980
pubmed: 34450083
Glob Pediatr Health. 2016 Feb 16;3:2333794X15625159
pubmed: 27335997
Med Sci Monit. 2018 Apr 02;24:1948-1954
pubmed: 29608553
PLoS One. 2018 Sep 13;13(9):e0203278
pubmed: 30212519
BMC Pediatr. 2019 Jul 20;19(1):244
pubmed: 31325963
J Am Coll Cardiol. 2007 Nov 20;50(21):2085-92
pubmed: 18021879
BMJ. 2000 May 6;320(7244):1240-3
pubmed: 10797032
Hypertension. 2004 Jan;43(1):25-30
pubmed: 14656958
Pan Afr Med J. 2014 Jan 25;17:57
pubmed: 25018807
Hypertension. 2001 Feb;37(2):187-93
pubmed: 11230269
J Pediatr (Rio J). 2018 Jan - Feb;94(1):48-55
pubmed: 28754602
Circulation. 2007 Sep 25;116(13):1488-96
pubmed: 17846287
BMJ. 2009 Nov 24;339:b4567
pubmed: 19934192
J Clin Hypertens (Greenwich). 2015 Oct;17(10):819-24
pubmed: 26140673
Am J Med Sci. 1995 Dec;310 Suppl 1:S22-8
pubmed: 7503119
BMC Endocr Disord. 2018 Nov 26;18(1):89
pubmed: 30477478
Rev Mal Respir. 2004 Sep;21(4 Pt 1):693-703
pubmed: 15536370
Nature. 2000 Apr 6;404(6778):635-43
pubmed: 10766250

Auteurs

Felicite Kamdem (F)

Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.
Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.

Elysée Claude Bika Léle (EC)

Physiology and Medicine of Physical Activities and Sports Unit, University of Douala, Douala, Cameroon.

Ba Hamadou (B)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Douala, Cameroon.

Marie Ange Prisca Obe Meyong (MAP)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Douala, Cameroon.

Jaff Fenkeu Kweban (J)

Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.

Oumarou Moussa (O)

Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.

Sidick Mouliom (S)

Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.
Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.

Lade Viché (L)

Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.
Faculty of Medicine and Biomedical Sciences, University of N'Gaoundéré, Douala, Cameroon.

Henri Ngoté (H)

Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.

Caroline Kenmegne (C)

Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.

Marie Solange Ndom Ebongue (MS)

Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.

Siddikatou Djibrilla (S)

Faculty of Health Sciences, University of Buea, Douala, Cameroon.

Anastase Dzudié (A)

Department of Internal Medicine, Douala General Hospital, Douala, Cameroon.
Physiology and Medicine of Physical Activities and Sports Unit, University of Douala, Douala, Cameroon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH